The present study also shows the positive expression of HER2 to be significantly more frequent in patients with invasive EMPD than in those with in situ/microinvasive EMPD, which suggests that HER2-positive tumor cells have increased invasive potential. Here, ERBB2 is linked to extramammary Paget disease.